The Company’s products include over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms.
Pliaglis is a topical local anaesthetic cream that provides safe and effective local dermal analgesia on intact skin prior to superficial dermatological procedures, such as dermal filler injection, pulsed dye laser therapy, facial laser resurfacing and laser-assisted tattoo removal. Crescita owns the marketing and development rights in Canada and Mexico and is licensed to Galderma SA for the Rest of World. Taro Pharmaceuticals owns the rights to sell and market Pliaglis in the U.S.
The skin care products were acquired through the acquisition of INTEGA Skin Sciences in September 2016. The focus of these products is the promotion of healthy skin through clinically proven quality dermatology products.